Individual circumstances : Does the patient have specific nutritional deficiencies or health conditions that might warrant supplementation
This is individual and requires experimentation guided by regular weigh-ins and ketone monitoring
Madsen CD, Pedersen JT, Venning FA, Singh LB, Moeendarbary E, Charras G, Cox TR, Sahai E, Erler JT (2015) Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis
As of now, BPC 157 is not an FDA-approved treatment, and more extensive human trials are necessary to establish its efficacy and safety profile
Sikiri P, Petek M, Ruman R, Seiwerth S, et al